Results Dare Bioscience Inc.
-
Health Catalyst Announces ~$5 Million Stock Repurchase
-5d
-
Immuneering Names Dr. Igor Matushansky as Chief Medical Officer
-6d
-
-6d
-
Immuneering Corporation Announces Grant of Inducement Award
-6d
-
Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference
-6d
-
Annual Report for Fiscal Year Ending December 31, 2024 (Form 10-K)
3/31
-
Failure to Satisfy Listing Rule (Form 8-K)
2/14
-
Regulation FD Presentation (Form 8-K)
2/10
-
Statement of Changes in Beneficial Ownership (Form 4)
1/31
-
Statement of Changes in Beneficial Ownership (Form 4)
1/31